139 related articles for article (PubMed ID: 35989349)
1. Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancer.
Huang H; Chen Y; Weng X; Li S; Zhang L; Chen P
Cancer Cell Int; 2022 Aug; 22(1):261. PubMed ID: 35989349
[TBL] [Abstract][Full Text] [Related]
2. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Zeng H; Huang WW; Liu YJ; Huang Q; Zhao SM; Li YL; Tian PW; Li WM
Front Oncol; 2021; 11():685047. PubMed ID: 34458139
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy.
Peng F; Qin T; Wang M; Wang H; Dang C; Wu CH; Tien YW; Qin R
Front Oncol; 2021; 11():734673. PubMed ID: 34660297
[TBL] [Abstract][Full Text] [Related]
5. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
[TBL] [Abstract][Full Text] [Related]
6. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
7. Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.
Yuan S; Xia Y; Shen L; Ye L; Li L; Chen L; Xie X; Lou H; Zhang J
Cancer Immunol Immunother; 2021 Feb; 70(2):533-546. PubMed ID: 32852602
[TBL] [Abstract][Full Text] [Related]
8. Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer.
Wang X; Guo Z; Wu X; Chen D; Wang F; Yang L; Luo M; Wu S; Yang C; Huang L; Fu L
Immunotargets Ther; 2023; 12():1-16. PubMed ID: 36632330
[TBL] [Abstract][Full Text] [Related]
9. Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment.
Liu Y; Ma H; Zhou R; Chen Y; Zhu Y; Chang X; Chen J; Zhang H
Heliyon; 2024 May; 10(10):e31449. PubMed ID: 38818171
[TBL] [Abstract][Full Text] [Related]
10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
11. Exploration of a novel prognostic model based on nomogram in non-small cell lung cancer patients with distant organ metastasis: implications for immunotherapy.
Wang M; Zhang Y; Liu M; Wang Y; Niu X; Qiu D; Xi H; Zhou Y; Chang N; Xu T; Xing L; Yamauchi Y; Terra RM; Tane S; Moon MH; Yan X; Zhao F; Zhang J
Transl Lung Cancer Res; 2023 Oct; 12(10):2040-2054. PubMed ID: 38025819
[TBL] [Abstract][Full Text] [Related]
12. Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination.
Wang Z; Li H; Liu T; Sun Z; Yang F; Jiang G
Front Oncol; 2021; 11():645486. PubMed ID: 34350108
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nomogram on clinicopathologic features and serum indicators for advanced non-small cell lung cancer patients treated with anti-PD-1 inhibitors.
Chai R; Fan Y; Zhao J; He F; Li J; Han Y
Ann Transl Med; 2020 Sep; 8(17):1078. PubMed ID: 33145297
[TBL] [Abstract][Full Text] [Related]
14. An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer.
Wu Y; Han C; Wang Z; Gong L; Liu J; Chong Y; Liu X; Liang N; Li S
Front Oncol; 2020; 10():1322. PubMed ID: 32850420
[No Abstract] [Full Text] [Related]
15. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
[TBL] [Abstract][Full Text] [Related]
16. Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram.
Xu S; Qi J; Li B; Li XG
Int J Hyperthermia; 2021; 38(1):640-649. PubMed ID: 33882774
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
18. Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas.
Zhang C; Liu Z; Tao J; Lin L; Zhai L
Cancer Manag Res; 2021; 13():9271-9285. PubMed ID: 34992453
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.
Xiao HF; Zhang BH; Liao XZ; Yan SP; Zhu SL; Zhou F; Zhou YK
Oncotarget; 2017 Sep; 8(38):64303-64316. PubMed ID: 28969072
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
Wang T; Lu R; Lai S; Schiller JH; Zhou FL; Ci B; Wang S; Gao X; Yao B; Gerber DE; Johnson DH; Xiao G; Xie Y
Cancer Inform; 2019; 18():1176935119837547. PubMed ID: 31057324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
